| Print
Bone Biologics Corp (BBLG)
Common SharesNot yet a customer?
Low cost dealing from £1.50Choose from our range of SIPP, ISA and Dealing accounts
Find out moreThis share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP
Company profile
Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.
Address
Forecast key dates
Name | Key Date |
---|---|
Bone Biologics Corp Second Quarter Earnings Results for 2026 | 2026-08-14T00:00:00 |
Bone Biologics Corp Annual General Meeting for 2026 | 2026-05-29T11:00:00 |
Bone Biologics Corp First Quarter Earnings Results for 2026 | 2026-05-12T00:00:00 |
Bone Biologics Corp Annual Report for 2025 | 2026-02-26T00:00:00 |
Bone Biologics Corp Third Quarter Earnings Results for 2025 | 2025-11-14T00:00:00 |
Previous key dates
Name | Key Date |
---|---|
H.C. Wainwright 27th Annual Global Investment Conference | 2025-09-08T00:00:00 |
Bone Biologics Corp Second Quarter Earnings Results for 2025 | 2025-08-14T00:00:00 |
Bone Biologics Corp Annual General Meeting for 2025 | 2025-05-30T11:00:00 |
Bone Biologics Corp First Quarter Earnings Results for 2025 | 2025-05-12T00:00:00 |
Bone Biologics Corp Annual Report for 2024 | 2025-02-26T00:00:00 |
Bone Biologics Corp Third Quarter Earnings Results for 2024 | 2024-11-14T00:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.